Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets.
about
Inflammatory breast cancer: New factors contribute to disease etiology: A reviewMMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.Developmental therapeutics for inflammatory breast cancer: Biology and translational directionsImportant Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic ChallengeClonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- VinorelbineInflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategiesCharacterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)Highly adaptable triple-negative breast cancer cells as a functional model for testing anticancer agents.miRNome of inflammatory breast cancer.Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer.Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical modelSurvival of women with inflammatory breast cancer: a large population-based studySystems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer.Epidemiological risk factors associated with inflammatory breast cancer subtypes.Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant ChemotherapyIn silico pathway analysis in cervical carcinoma reveals potential new targets for treatment.Risk factors for inflammatory breast cancer and other invasive breast cancers.Presence of anaplastic lymphoma kinase in inflammatory breast cancerEZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells.Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survivalComparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.MARCKS protein overexpression in inflammatory breast cancer.Management of locally advanced breast cancer-perspectives and future directions.Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells.Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase.Identification of frequent somatic mutations in inflammatory breast cancer.Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival.Early prognosis of metastasis risk in inflammatory breast cancer by texture analysis of tumour microscopic images.MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.IBC as a Rapidly Spreading Systemic Disease: Clinical and Targeted Approaches Using the Neoadjuvant Model.Abdominal Wall Reconstruction after Flap Surgery and the Effect on the Immune System.Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.Analysis of Hierarchical Organization in Gene Expression Networks Reveals Underlying Principles of Collective Tumor Cell Dissemination and Metastatic Aggressiveness of Inflammatory Breast Cancer.Potential new biomarkers for squamous carcinoma of the uterine cervix.Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
P2860
Q27027856-75CB39DD-BFEA-47BD-8BEF-90D78C6E151DQ27853354-73AA7F93-6966-4DAD-AA1B-9311DF05FC39Q28075322-4D620F2A-7149-4314-AC11-D9C846B19F86Q28552551-64FA70D7-074E-4EE1-9D03-0967D6428DBBQ28554790-44BA7CA5-5D40-4C58-9B0F-3000D468B4AEQ33688446-F882261B-5B57-4C8E-B315-3E9BA7E9AF00Q33796945-61AF867B-1B84-4814-8360-3F486E88CECFQ34287510-AD8299DE-056C-4AED-A211-0412F51F449CQ34896961-D80FDD46-CE51-4B58-AC90-5FFAE92AA42FQ35183637-5B91871C-2ED7-4997-B115-13B2C2BE0F0CQ35313206-08E03E7C-92C0-4C56-814D-4312ABDD5DF6Q35608330-0B8C7E36-F21E-410F-B002-084F851D9D10Q35619119-2A8B77EC-2D6A-4698-AAF8-E7868BCDFE4CQ35825566-5C0CA294-B7E6-40D4-AD52-38C4E4F746C2Q36652833-35D93D01-9AA5-490B-A734-EA26A81AACE2Q36693275-4566309C-F362-40DD-9723-F5823F7472B8Q36771946-AC8E4F31-EA02-45AC-97F6-40BE3CCDD25FQ37180368-515157FC-AE94-440F-BC3A-EE944AF3AD8AQ37216951-FF55FCBB-81BF-419E-82A4-87C29E18B563Q37362586-3088A01C-436E-4128-B72E-D1758C3A68ECQ37518882-C1FCA675-6C42-419F-9115-A03C23186AE3Q37528475-070C8593-21BF-4C15-8172-C9E8DA685BBCQ37690619-6CE583F0-5202-4DF9-87FD-4634697B78E7Q37701585-ED54B834-56BC-4C54-8CB2-02BF8E3D34C6Q38350939-717224FA-B005-4043-BC08-39BCF7E4ECF2Q38706762-620D8BFB-7A23-4A69-ADE1-7347E7C9C129Q38923177-63DF20D6-77C8-4BAA-86E1-5296FE2578BBQ38938061-2AC3803A-7886-4224-9065-7CB2D5BF7182Q39399420-46C669B6-E25E-483A-84DF-86CE9FF444B7Q40078894-429C4AAA-462A-4CDB-BDF7-57616D6F1600Q40306478-420CA7C4-0AB9-4B0D-BA35-C6B50DD76F76Q40887298-401E2D62-3279-4B52-AE78-80A1FCF985C7Q42478176-295B5A98-2CE0-4FA2-888F-17FF9FA14D63Q45922929-C605AF6C-0077-4ECE-96F9-59D9BE28065EQ51023485-181D1745-9B9E-4676-8D9E-2D8B107E8575Q54967454-CA85DBD7-EC11-4655-992B-9640F047EB97Q55332314-A3C7943A-8DBC-41B1-A134-B6E99BF44D2CQ55691533-0CCC439D-D165-4251-9E03-7ACBF440B083Q55715397-05566484-7E78-4EE0-BF1F-4E41E835F420Q58797604-3BFEA5CB-0E19-4254-9A15-85F4B98BB9BA
P2860
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Uncovering the molecular secre ...... trix gene expression datasets.
@en
Uncovering the molecular secre ...... trix gene expression datasets.
@nl
type
label
Uncovering the molecular secre ...... trix gene expression datasets.
@en
Uncovering the molecular secre ...... trix gene expression datasets.
@nl
prefLabel
Uncovering the molecular secre ...... trix gene expression datasets.
@en
Uncovering the molecular secre ...... trix gene expression datasets.
@nl
P2093
P2860
P1476
Uncovering the molecular secre ...... trix gene expression datasets.
@en
P2093
Anthony Lucci
Daniel Birnbaum
François Bertucci
Fredika M Robertson
Hiroko Masuda
James M Reuben
Massimo Cristofanilli
Melike Marsan
Naoto T Ueno
P2860
P304
P356
10.1158/1078-0432.CCR-12-2549
P407
P577
2013-02-08T00:00:00Z